financetom
Business
financetom
/
Business
/
Leidos lifts 2024 forecasts on defense demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Leidos lifts 2024 forecasts on defense demand
Apr 30, 2024 4:08 AM

April 30 (Reuters) - U.S. defense company Leidos

Holdings ( LDOS ) lifted its annual profit and revenue forecasts

on Tuesday, banking on strong weapons demand and increased

defense spending amid growing geopolitical tensions.

Defense companies are seeing robust demand for weapons from

the United States and its allies following Russia's invasion of

Ukraine, conflict in the Middle East and rising tensions in the

South China Sea.

Leidos ( LDOS ), engaged in hypersonic weapons development, among

others, expects its adjusted full-year profit per share to be

between $8.40 and $8.80, compared with its previous forecast

range of $7.50 to $7.90.

The Reston, Virginia-based company, which counts the U.S.

Department of Defense as its primary customer, also lifted its

2024 revenue forecast range to $16 billion to $16.4 billion,

versus $15.7 billion to $16.1 billion projected in January.

Leidos' ( LDOS ) adjusted profit for the first quarter was at $2.29

per share, compared with $1.47 per share a year ago.

Its quarterly revenue jumped 7.4% to $3.98 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Palisade Bio Begins Dosing Ulcerative Colitis Patients in PALI-2108 Trial
Palisade Bio Begins Dosing Ulcerative Colitis Patients in PALI-2108 Trial
Mar 14, 2025
08:57 AM EDT, 03/14/2025 (MT Newswires) -- Palisade Bio ( PALI ) said Friday it began dosing ulcerative colitis patients in the final cohort of its phase 1a/b study of PALI-2108. The company said it had completed five single ascending dose cohorts and three of four multiple ascending dose cohorts, with no serious adverse events or treatment-related adverse events tied...
Market Chatter: Panama Signals It's Ready to Negotiate On Shuttered First Quantum Copper Mine
Market Chatter: Panama Signals It's Ready to Negotiate On Shuttered First Quantum Copper Mine
Mar 14, 2025
08:57 AM EDT, 03/14/2025 (MT Newswires) -- First Quantum Minerals Ltd. ( FQVLF ) was cleared to begin shipping out stockpiled copper in Panama, the latest sign authorities may be willing to negotiate a restart of the company's giant shuttered mine, Bloomberg News is reporting Friday. It noted Panama's President Jose Raul Mulino said Thursday he has authorized the export...
Scotiabank Previews Carney Likely First Actions as Canada's Prime Minister
Scotiabank Previews Carney Likely First Actions as Canada's Prime Minister
Mar 14, 2025
08:55 AM EDT, 03/14/2025 (MT Newswires) -- Mark Carney will be officially sworn in as prime minister of Canada at 11 a.m. ET Friday, noted Scotiabank. Among his first actions on the job will be to kill the carbon tax and then secure meetings with key international leaders, said the bank. Carney's reportedly off to Europe next week to build...
DocuSign's IAM Driving Growth Needs More 'Proof Points,' RBC Says
DocuSign's IAM Driving Growth Needs More 'Proof Points,' RBC Says
Mar 14, 2025
08:57 AM EDT, 03/14/2025 (MT Newswires) -- DocuSign ( DOCU ) reported solid fiscal Q4 results with strong billings growth, but the case for its Intelligent Agreement Management product driving growth needs more clarity, RBC Capital Markets said in a Thursday note. The company's outperformance in billings, which was driven by early renewals, along with increasing usage, were encouraging data...
Copyright 2023-2026 - www.financetom.com All Rights Reserved